Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
DpyhdawYdWF8FCSx
Listen
